TCM
TGTX icon

Tang Capital Management’s TG Therapeutics TGTX Stock Holding History

Tang Capital Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100,000
Closed -$3.61M – 175
2025
Q3 		$3.61M Hold
100,000
– – 0.14% 102
2025
Q2 		$3.6M Hold
100,000
– – 0.18% 99
2025
Q1 		$3.94M Hold
100,000
– – 0.22% 84
2024
Q4 		$3.01M Hold
100,000
– – 0.2% 92
2024
Q3 		$2.34M Hold
100,000
– – 0.17% 97
2024
Q2 		$1.78M Hold
100,000
– – 0.18% 81
2024
Q1 		$1.52M Hold
100,000
– – 0.16% 82
2023
Q4 		$1.71M Hold
100,000
– – 0.16% 97
2023
Q3 		$836K Buy
+100,000
New +$1.39M 0.12% 88

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Tang Capital Management's TGTX Position: Q4 2025 in Review

Tang Capital Management sold out of TG Therapeutics (TGTX) in Q4 2025, closing a stake of 100,000 shares — an estimated $3.61M sold.

Tang Capital Management first reported a position in TGTX in Q3 2023 and held it in 9 quarters. The position peaked at $3.94M in Q1 2025. 351 funds tracked by Wall St. Rank hold TGTX as of Q4 2025.

  • Tang Capital Management reported no remaining TG Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Tang Capital Management sold 100,000 TG Therapeutics shares in Q4 2025, an estimated $3.61M.
  • Tang Capital Management first reported a position in TG Therapeutics in Q3 2023 and held it in 9 quarters.
  • Tang Capital Management's TG Therapeutics position peaked at $3.94M in Q1 2025.
  • 351 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2025.

Based on Tang Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.